Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pierce

Showing results (521-530 of 548) with videos related to

Pageof 55
Sort By:
Cancer Research|March 21, 1998
Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortalityC L Farrell, J V Bready, K L Rex, et al.
Research and Practice in Thrombosis and Haemostasis|April 16, 2025
Development of a novel gene editing lexicon for hemophilia: methodology and resultsCraig M Kessler, Leonard A Valentino, Courtney D Thornburg, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate CancerBrian L Heiss, Elaine Chang, Xin Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2023
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate CancerJaleh Fallah, Jianjin Xu, Chana Weinstock, et al.
The New England Journal of Medicine|March 16, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia AMargareth C Ozelo, Johnny Mahlangu, K John Pasi, et al.
Nature Communications|March 17, 2022
Medial prefrontal cortex and anteromedial thalamus interaction regulates goal-directed behavior and dopaminergic neuron activityChen Yang, Yuzheng Hu, Aleksandr D Talishinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situBrian L Heiss, Elaine Chang, Hee-Koung Joeng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 25, 2025
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025Glenn F Pierce, Margareth C Ozelo, Johnny Mahlangu, et al.
Pageof 55

Showing results (521-530 of 548) with videos related to

Sort By:
Pageof 55
Cancer Research|March 21, 1998
Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortalityC L Farrell, J V Bready, K L Rex, et al.
Research and Practice in Thrombosis and Haemostasis|April 16, 2025
Development of a novel gene editing lexicon for hemophilia: methodology and resultsCraig M Kessler, Leonard A Valentino, Courtney D Thornburg, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2024
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate CancerBrian L Heiss, Elaine Chang, Xin Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2023
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate CancerJaleh Fallah, Jianjin Xu, Chana Weinstock, et al.
The New England Journal of Medicine|March 16, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia AMargareth C Ozelo, Johnny Mahlangu, K John Pasi, et al.
Nature Communications|March 17, 2022
Medial prefrontal cortex and anteromedial thalamus interaction regulates goal-directed behavior and dopaminergic neuron activityChen Yang, Yuzheng Hu, Aleksandr D Talishinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situBrian L Heiss, Elaine Chang, Hee-Koung Joeng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 25, 2025
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025Glenn F Pierce, Margareth C Ozelo, Johnny Mahlangu, et al.
Pageof 55